These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35860248)

  • 1.
    Zhou L; Xie Y; Li Y
    Front Immunol; 2022; 13():871705. PubMed ID: 35860248
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhou LY; Xie Y; Li Y
    World J Gastroenterol; 2022 Jul; 28(26):3164-3176. PubMed ID: 36051332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.
    Song L; Liu S; Zhao S
    Bioengineered; 2022 Apr; 13(4):11240-11257. PubMed ID: 35485300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.
    Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y
    Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhou L; Liu D; Xie Y; Yao X; Li Y
    Gut Liver; 2019 Mar; 13(4):430-439. PubMed ID: 30600673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
    Dong L; Lv H; Li W; Song Z; Li L; Zhou S; Qiu L; Qian Z; Liu X; Feng L; Meng B; Fu K; Wang X; Pan-Hammarström Q; Wang P; Wang X; Zhang H
    Oncotarget; 2016 May; 7(22):33350-62. PubMed ID: 27147575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii excreted-secreted antigens suppress Foxp3 via PI3K-AKT-mTOR signaling pathway.
    Chen J; Hu L; Wang J; Cao Y; Zhu D; Chen L; Duan Y
    J Cell Biochem; 2019 Sep; 120(9):16044-16051. PubMed ID: 31074049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway.
    Pei XD; Yao HL; Shen LQ; Yang Y; Lu L; Xiao JS; Wang XY; He ZL; Jiang LH
    Eur J Pharmacol; 2020 Sep; 883():173355. PubMed ID: 32687921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines.
    Fiedler M; Schulz D; Piendl G; Brockhoff G; Eichberger J; Menevse AN; Beckhove P; Hautmann M; Reichert TE; Ettl T; Bauer RJ
    Exp Cell Res; 2020 Nov; 396(1):112259. PubMed ID: 32898555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer.
    Spirina LV; Avgustinovich AV; Afanas'ev SG; Kondakova IV; Volkov MY; Dobrodeev AY; Boronkina AI
    Bull Exp Biol Med; 2020 Nov; 170(1):75-78. PubMed ID: 33231797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.
    Lu Y; Zhong W; Liu Y; Chen W; Zhang J; Zeng Z; Huang H; Qiao Y; Wan X; Meng X; Cai S; Dong H
    Int Immunopharmacol; 2022 Mar; 104():108504. PubMed ID: 35026657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
    Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
    Han K; Zhang Y
    J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breastmilk-derived
    Ding M; Li B; Chen H; Liang D; Ross RP; Stanton C; Zhao J; Chen W; Yang B
    Gut Microbes; 2024; 16(1):2290344. PubMed ID: 38116652
    [No Abstract]   [Full Text] [Related]  

  • 16. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.
    Yang L; Huang F; Mei J; Wang X; Zhang Q; Wang H; Xi M; You Z
    Int J Gynecol Cancer; 2017 Feb; 27(2):196-205. PubMed ID: 27870715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles  produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis.
    He H; Chen Q; Fan H; Leng XY; Zhu F; Gao F; Zhou Q; Dong Y; Yang J
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2243-2254. PubMed ID: 36044618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.